IRCT201507035623N47CompletedPhase 3
Clinical trial of the effect of combined omega-3 and vitamin E supplementation on pregnancy outcomes in gestational diabetes
Vice chancellor for research, Arak University of Medical Sciences0 sites60 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 40 years (—)
- Sex
- Female
Inclusion Criteria
- •Pregnant women aged 18-40 years
- •Diagnosed with GDM at 24-28 week gestation
Exclusion Criteria
- •Placenta abruption
- •Preeclampsia
- •Hypo- and hyperthyroidism
- •Urinary tract infection
- •Kidney or liver diseases
Investigators
Similar Trials
Completed
Phase 2
Effect of combined omega-3 and vitamin D supplementation in treatment of multiple sclerosisMultiple Sclerosis.Demyelinating disease of the central nervous systemIRCT2017090133941N20Kashan University of Medical Sciences60
Completed
Phase 3
Effect of supplementation in treatment of women with polycystic ovary syndromePolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2IRCT201704245623N114Vice chancellor for research, Arak University of Medical Sciences60
Completed
Phase 3
Effect of combined omega-3 and vitamin D supplementation in treatment of coronary heart diseaseCoronary Heart Disease.Chronic ischaemic heart disease, unspecifiedI25.9IRCT2017090133941N15Kashan University of Medical Sciences74
Completed
Phase 3
Effect of supplementation in treatment of patients with gestational diabetesIRCT201701305623N106Vice chancellor for research, Ardabil University of Medical Sciences120
Completed
Phase 3
Effect of supplementation in treatment of patients with gestational diabetesGestational diabetes.Diabetes mellitus in pregnancy, unspecifiedO24.9IRCT201605135623N78Vice chancellor for research, Arak University of Medical Sciences140
